Mativ (NYSE:MATV - Get Free Report) was upgraded by equities researchers at Wall Street Zen from a "hold" rating to a "buy" rating in a note issued to investors on Saturday.
Mativ Trading Up 3.6%
Shares of NYSE:MATV traded up $0.37 during trading on Friday, reaching $10.78. 433,502 shares of the company traded hands, compared to its average volume of 795,663. The firm has a market capitalization of $589.56 million, a price-to-earnings ratio of -1.29 and a beta of 0.73. Mativ has a 52-week low of $4.34 and a 52-week high of $19.96. The company has a current ratio of 2.37, a quick ratio of 1.21 and a debt-to-equity ratio of 2.65. The business's fifty day moving average is $7.15 and its 200-day moving average is $6.71.
Mativ (NYSE:MATV - Get Free Report) last released its quarterly earnings results on Wednesday, August 6th. The company reported $0.33 EPS for the quarter, beating analysts' consensus estimates of $0.18 by $0.15. The business had revenue of $525.40 million during the quarter, compared to analyst estimates of $505.00 million. Mativ had a positive return on equity of 4.12% and a negative net margin of 23.09%. As a group, analysts forecast that Mativ will post 1.15 EPS for the current year.
Insider Buying and Selling
In other news, Director Kimberly E. Ritrievi bought 10,000 shares of Mativ stock in a transaction on Thursday, May 29th. The shares were purchased at an average price of $5.88 per share, for a total transaction of $58,800.00. Following the acquisition, the director owned 30,640 shares of the company's stock, valued at approximately $180,163.20. The trade was a 48.45% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Shruti Singhal bought 40,000 shares of Mativ stock in a transaction on Thursday, May 29th. The shares were purchased at an average price of $5.76 per share, for a total transaction of $230,400.00. Following the acquisition, the chief executive officer directly owned 56,533 shares in the company, valued at approximately $325,630.08. This trade represents a 241.94% increase in their position. The disclosure for this purchase can be found here. 0.96% of the stock is currently owned by corporate insiders.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently made changes to their positions in MATV. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of Mativ by 3.8% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 30,724 shares of the company's stock worth $335,000 after buying an additional 1,121 shares during the last quarter. MetLife Investment Management LLC grew its stake in shares of Mativ by 5.7% in the 4th quarter. MetLife Investment Management LLC now owns 33,153 shares of the company's stock worth $361,000 after buying an additional 1,779 shares during the last quarter. GAMMA Investing LLC grew its stake in shares of Mativ by 119.7% in the 1st quarter. GAMMA Investing LLC now owns 4,462 shares of the company's stock worth $28,000 after buying an additional 2,431 shares during the last quarter. Federated Hermes Inc. purchased a new stake in shares of Mativ in the 4th quarter worth approximately $33,000. Finally, US Bancorp DE grew its stake in shares of Mativ by 204.2% in the 1st quarter. US Bancorp DE now owns 5,677 shares of the company's stock worth $35,000 after buying an additional 3,811 shares during the last quarter. Hedge funds and other institutional investors own 94.95% of the company's stock.
About Mativ
(
Get Free Report)
Mativ Holdings, Inc, together with its subsidiaries, manufactures and sells specialty materials in the United States, Europe, the Asia Pacific, the Americas, and internationally. The company operates through two segments, Advanced Technical Materials and Fiber-Based Solutions. The Advanced Technical Materials manufactures and sells various engineered polymer, resin and fiber-based substrates, nets, films, adhesive tapes, and other nonwovens for the filtration, protective solutions, release liners, and healthcare end-markets.
Further Reading
Before you consider Mativ, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mativ wasn't on the list.
While Mativ currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access